GENEVA, Feb. 17 -- DIAGENODE S.A. (Rue Bois Saint-Jean, 34102 Seraing (Ougree)) filed a patent application (PCT/EP2025/072510) for "SYRINGE FOR FRAGMENTING NUCLEIC ACID SAMPLE MATERIAL" on Aug 05, 2025. With publication no. WO/2026/032981, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WASSIM, Lakhal (c/o Diagenode S.A.Rue Bois Saint-Jean, 34102 Seraing (Ougree))
Abstract: The present disclosure relates to a syringe (1) for fragmenting nucleic acid sample material in liquid, the syringe (1) comprising a syringe body (2)...